3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine

C139H149F6N37O8 — CID 158278593

IUPAC3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)C(=O)c1cccc(-c2cnc(N)c3nc(C4CCCNC4)cn23)c1.COc1ccc(CNC(=O)c2ccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)cc2)cc1.COc1ccc([C@H](C)NC(=O)c2cccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)c2)cc1.Cn1cc(-c2c(C3CCNC3)nc3c(N)nccn23)cn1.Nc1ncc(-c2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12.Nc1ncc(-c2cccc(C(=O)NCc3ccc(OC(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12
InChIInChI=1S/C27H30N6O2.C26H25F3N6O2.C26H25F3N6O.C26H28N6O2.C20H24N6O.C14H17N7/c1-17(18-8-10-22(35-2)11-9-18)31-27(34)20-6-3-5-19(13-20)24-15-30-25(28)26-32-23(16-33(24)26)21-7-4-12-29-14-21;27-26(28,29)37-20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;27-26(28,29)20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;1-34-21-10-4-17(5-11-21)13-30-26(33)19-8-6-18(7-9-19)23-15-29-24(27)25-31-22(16-32(23)25)20-3-2-12-28-14-20;1-25(2)20(27)14-6-3-5-13(9-14)17-11-23-18(21)19-24-16(12-26(17)19)15-7-4-8-22-10-15;1-20-8-10(7-18-20)12-11(9-2-3-16-6-9)19-14-13(15)17-4-5-21(12)14/h3,5-6,8-11,13,15-17,21,29H,4,7,12,14H2,1-2H3,(H2,28,30)(H,31,34);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);4-11,15-16,20,28H,2-3,12-14H2,1H3,(H2,27,29)(H,30,33);3,5-6,9,11-12,15,22H,4,7-8,10H2,1-2H3,(H2,21,23);4-5,7-9,16H,2-3,6H2,1H3,(H2,15,17)/t17-,21?;;;;;/m0...../s1
InChIKeyGJXQNXVIHAKEES-MQSYMXASSA-N
MW2579.96 g/mol
LogP18.93
Rot. Bonds28

About 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine

3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine (PubChem CID 158278593) has the molecular formula C139H149F6N37O8 and a molecular weight of 2579.96 g/mol. Its IUPAC name is 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

Compound Name3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine
PubChem CID158278593
Molecular FormulaC139H149F6N37O8
Molecular Weight2579.96 g/mol
Exact Mass2578.23
IUPAC Name3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)C(=O)c1cccc(-c2cnc(N)c3nc(C4CCCNC4)cn23)c1.COc1ccc(CNC(=O)c2ccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)cc2)cc1.COc1ccc([C@H](C)NC(=O)c2cccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)c2)cc1.Cn1cc(-c2c(C3CCNC3)nc3c(N)nccn23)cn1.Nc1ncc(-c2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12.Nc1ncc(-c2cccc(C(=O)NCc3ccc(OC(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12
InChIInChI=1S/C27H30N6O2.C26H25F3N6O2.C26H25F3N6O.C26H28N6O2.C20H24N6O.C14H17N7/c1-17(18-8-10-22(35-2)11-9-18)31-27(34)20-6-3-5-19(13-20)24-15-30-25(28)26-32-23(16-33(24)26)21-7-4-12-29-14-21;27-26(28,29)37-20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;27-26(28,29)20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;1-34-21-10-4-17(5-11-21)13-30-26(33)19-8-6-18(7-9-19)23-15-29-24(27)25-31-22(16-32(23)25)20-3-2-12-28-14-20;1-25(2)20(27)14-6-3-5-13(9-14)17-11-23-18(21)19-24-16(12-26(17)19)15-7-4-8-22-10-15;1-20-8-10(7-18-20)12-11(9-2-3-16-6-9)19-14-13(15)17-4-5-21(12)14/h3,5-6,8-11,13,15-17,21,29H,4,7,12,14H2,1-2H3,(H2,28,30)(H,31,34);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);4-11,15-16,20,28H,2-3,12-14H2,1H3,(H2,27,29)(H,30,33);3,5-6,9,11-12,15,22H,4,7-8,10H2,1-2H3,(H2,21,23);4-5,7-9,16H,2-3,6H2,1H3,(H2,15,17)/t17-,21?;;;;;/m0...../s1
InChIKeyGJXQNXVIHAKEES-MQSYMXASSA-N
XLogP18.93
TPSA591.66 Ų
H-Bond Donors16
H-Bond Acceptors40
Rotatable Bonds28
Heavy Atoms190
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002579.96
LogP ≤ 518.93
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1040

Analyze 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine (CID 158278593) is 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine is CN(C)C(=O)c1cccc(-c2cnc(N)c3nc(C4CCCNC4)cn23)c1.COc1ccc(CNC(=O)c2ccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)cc2)cc1.COc1ccc([C@H](C)NC(=O)c2cccc(-c3cnc(N)c4nc(C5CCCNC5)cn34)c2)cc1.Cn1cc(-c2c(C3CCNC3)nc3c(N)nccn23)cn1.Nc1ncc(-c2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12.Nc1ncc(-c2cccc(C(=O)NCc3ccc(OC(F)(F)F)cc3)c2)n2cc(C3CCCNC3)nc12.
What is the InChIKey of 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine?
The InChIKey is GJXQNXVIHAKEES-MQSYMXASSA-N. The full InChI is InChI=1S/C27H30N6O2.C26H25F3N6O2.C26H25F3N6O.C26H28N6O2.C20H24N6O.C14H17N7/c1-17(18-8-10-22(35-2)11-9-18)31-27(34)20-6-3-5-19(13-20)24-15-30-25(28)26-32-23(16-33(24)26)21-7-4-12-29-14-21;27-26(28,29)37-20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;27-26(28,29)20-8-6-16(7-9-20)12-33-25(36)18-4-1-3-17(11-18)22-14-32-23(30)24-34-21(15-35(22)24)19-5-2-10-31-13-19;1-34-21-10-4-17(5-11-21)13-30-26(33)19-8-6-18(7-9-19)23-15-29-24(27)25-31-22(16-32(23)25)20-3-2-12-28-14-20;1-25(2)20(27)14-6-3-5-13(9-14)17-11-23-18(21)19-24-16(12-26(17)19)15-7-4-8-22-10-15;1-20-8-10(7-18-20)12-11(9-2-3-16-6-9)19-14-13(15)17-4-5-21(12)14/h3,5-6,8-11,13,15-17,21,29H,4,7,12,14H2,1-2H3,(H2,28,30)(H,31,34);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);1,3-4,6-9,11,14-15,19,31H,2,5,10,12-13H2,(H2,30,32)(H,33,36);4-11,15-16,20,28H,2-3,12-14H2,1H3,(H2,27,29)(H,30,33);3,5-6,9,11-12,15,22H,4,7-8,10H2,1-2H3,(H2,21,23);4-5,7-9,16H,2-3,6H2,1H3,(H2,15,17)/t17-,21?;;;;;/m0...../s1.
What are the key properties of 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine?
3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine has a molecular weight of 2579.96 g/mol, XLogP of 18.93, 28 rotatable bonds, 16 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N,N-dimethylbenzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(1S)-1-(4-methoxyphenyl)ethyl]benzamide;4-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[(4-methoxyphenyl)methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethoxy)phenyl]methyl]benzamide;3-(8-amino-2-piperidin-3-ylimidazo[1,2-a]pyrazin-5-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide;3-(1-methylpyrazol-4-yl)-2-pyrrolidin-3-ylimidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 158278593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).